Latest news

Search
Categories
News archive

Nanologica Announces Date Change for Interim Reports for First and Second Quarter

Nanologica AB (publ) has changed the previously disclosed publication date of May 7, 2021 for the Company’s interim report for the first quarter 2021 to April 23, 2021.   In addition, the date for the interim report for the second quarter 2021 has been changed from August 27, 2021 to July 9, 2021.   Financial calendar 2021 Interim report January-March 2021                         April 23, 2021 Annual Report 2020                 

Read more »

Nanologica ändrar datum för publicering av delårsrapporter för första och andra kvartalet

Nanologica AB (publ) har ändrat datum för publicering av bolagets delårsrapport för första kvartalet 2021 från den 7 maj till den 23 april.   Utöver detta har bolaget ändrat datum för publicering av delårsrapport för andra kvartalet 2021 från den 27 augusti till den 9 juli.   Finansiell kalender 2021 Delårsrapport januari-mars 2021                            23 april, 2021 Årsredovisning 2020         

Read more »

Nanologica to Attend BIO-Europe Spring March 22-25 for Partnering Discussions

Nanologica will be attending BIO-Europe Spring, March 22-25, to meet with potential pharmaceutical partners regarding drug delivery applications using NLAB Spiro® and NLAB Silica™. Nanologica’s drug delivery platforms NLAB Spiro® and NLAB Silica™ consists of nanoporous particles where APIs can be placed inside the pores. By loading the API into the particles, Nanologica can overcome several of the challenges that prevent or limit effective treatment of many serious diseases. Some of the technical benefits of

Read more »

CEO Comment Fourth Quarter 2020

STRONG PERFORMANCE AND INVESTMENTS FOR THE FUTURE 2020 has been a challenging year, but it is with both delight and pride I can look back on the year and the progress we have made within both our business areas. Nanologica’s strong growth continued and we reached record net sales for the Company so far, at the same time as we made large investments to be able to create value over time. We passed a large

Read more »